HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Guevara-Hoyer Selected Research

typhoid Vi polysaccharide vaccine (Typhim Vi)

1/2020Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies.
1/2020Typhim vi immunization assists to discriminate primary antibody responses in hematological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Guevara-Hoyer Research Topics

Disease

1Infections
01/2020
1Neoplasms (Cancer)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020

Drug/Important Bio-Agent (IBA)

2Polysaccharides (Glycans)IBA
01/2020 - 01/2020
2typhoid Vi polysaccharide vaccine (Typhim Vi)FDA Link
01/2020 - 01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1AntigensIBA
01/2020

Therapy/Procedure

1Therapeutics
01/2020